跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Adalimumab Solution for Injection
Approved
生物制品
Adalimumab Solution for Injection
AbbVie Deutschland GmbH & Co. KG
🇨🇳 National Medical Products Administration
Approval Date
Mar 26, 2020
Approval ID
7w10teggVtK
Company
AbbVie Deutschland GmbH & Co. KG
Type
生物制品
Approval Details
Approval Id
7w10teggVtK
Approval Number
S20200007
Generic Name
阿达木单抗注射液
Generic Name En
Adalimumab Solution for Injection
Trade Name
修美乐
Brand Name
修美乐
Drug Type
生物制品
Dosage Form
注射剂
Strength
20mg/0.2ml
Reg Date
2020-03-26
Expired Date
2025-03-25
Company Name
AbbVie Deutschland GmbH & Co. KG
Company Address
Knollstrasse, 67061 Ludwigshafen, Germany
Production Company Name
vetter pharma-fertigung gmbh & co.kg
Production Company Address
Schützenstrasse 87 and 99-101, 88212 Ravensburg, Germany
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 26, 2020
Approval ID
7w10teggVtK
Type
生物制品
Back to NMPA Approvals
修美乐 - NMPA Drug Approval Details